Get the Stockscreener App
5.01
3.73%
0.18
Pre-market:
5.04
0.03
+0.60%
Olema Pharmaceuticals Inc stock is traded at $5.01, with a volume of 760.35K.
It is up +3.73% in the last 24 hours and up +8.44% over the past month.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
See More
Previous Close:
$4.83
Open:
$4.87
24h Volume:
760.35K
Relative Volume:
1.04
Market Cap:
$342.79M
Revenue:
-
Net Income/Loss:
$-96.66M
P/E Ratio:
-2.3302
EPS:
-2.15
Net Cash Flow:
$-83.73M
1W Performance:
+10.35%
1M Performance:
+8.44%
6M Performance:
-19.32%
1Y Performance:
-67.02%
1-Day Range:
$4.72
$5.035
1-Week Range:
$4.49
$5.035
52-Week Range:
$2.86
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Name
Olema Pharmaceuticals Inc
Sector
Industry
Phone
(415) 651-3316
Address
780 BRANNAN STREET, SAN FRANCISCO
Compare OLMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.01 | 330.47M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-24 | Initiated | Goldman | Buy |
| Jan-30-24 | Initiated | Citigroup | Buy |
| Jul-21-23 | Initiated | Oppenheimer | Outperform |
| May-05-23 | Initiated | CapitalOne | Overweight |
| Feb-22-23 | Initiated | Credit Suisse | Outperform |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Jun-09-22 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-28-22 | Initiated | H.C. Wainwright | Neutral |
| Dec-07-21 | Resumed | Cowen | Outperform |
| Dec-14-20 | Initiated | Canaccord Genuity | Buy |
| Dec-14-20 | Initiated | Cowen | Outperform |
| Dec-14-20 | Initiated | JP Morgan | Overweight |
| Dec-14-20 | Initiated | Jefferies | Buy |
View All
Olema Pharmaceuticals Inc Stock (OLMA) Latest News
Key metrics from Olema Pharmaceuticals Inc.’s quarterly dataMarket Opportunity Tracker for Swing Traders - Newser
Advanced analytics toolkit walkthrough for Olema Pharmaceuticals Inc.Short Term Opportunity Finder with Tools - Newser
Can a trend reversal in Olema Pharmaceuticals Inc. lead to recoverySwing Trade Entry and Exit Point Analysis - Newser
How hedge fund analytics apply to Olema Pharmaceuticals Inc. stockBreakout Screener With Alert Based Timing - Newser
How institutional ownership impacts Olema Pharmaceuticals Inc. stockReal-Time Entry Forecast with Accuracy Metrics - Newser
Olema Pharmaceuticals (OLMA) Expected to Announce Earnings on Tuesday - MarketBeat
Using fundamentals and technicals on Olema Pharmaceuticals Inc.Daily Stock Watch Summary with Key Insights - Newser
Olema Pharmaceuticals Inc. stock trend forecastDaily Exit and Entry Price Prediction - Newser
What makes Olema Pharmaceuticals Inc. stock price move sharplyShort-Term Bounce Forecast for Oversold Stocks - Newser
How does Olema Pharmaceuticals Inc. compare to its industry peersEarnings Report Alerts For Every Investor - jammulinksnews.com
Does Olema Pharmaceuticals Inc. stock perform well during market downturnsSkyrocketing returns - jammulinksnews.com
What is the risk reward ratio of investing in Olema Pharmaceuticals Inc. stockEarnings Report Strategy With High Returns - jammulinksnews.com
Combining price and volume data for Olema Pharmaceuticals Inc.Free Stock Market Watch With Alerts - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holdersFree Verified Signal From Chart Patterns - Newser
Olema Pharmaceuticals Inc. stock trend forecast Free High Return Stock Focus With Safety - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holders Risk Shielded Trade Watch with Analysis - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holders Free Stock Screener With Smart Filters - metal.it
Is Olema Pharmaceuticals Inc. stock overvalued or undervaluedTop Growth Planner That Work - jammulinksnews.com
What catalysts could drive Olema Pharmaceuticals Inc. stock higher in 2025Unlock powerful trading strategies for gains - jammulinksnews.com
What are Olema Pharmaceuticals Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - jammulinksnews.com
What are the latest earnings results for Olema Pharmaceuticals Inc.Maximize gains with strategic stock entries - jammulinksnews.com
Olema Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowFree Stock Trading Signals - Newser
How Interest Rate Changes Impact Olema Pharmaceuticals Inc. Stock PerformanceProven Trading Plan - Newser
Is Olema Pharmaceuticals Inc. a good long term investmentFree Investment Case Studies - PrintWeekIndia
What analysts say about Olema Pharmaceuticals Inc. stockConsistently outstanding ROI - Autocar Professional
Olema Pharmaceuticals Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com
What drives Olema Pharmaceuticals Inc. stock priceConsistently high yield - jammulinksnews.com
Olema Pharmaceuticals Inc Stock (OLMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.28%
2.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):